Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Gel Manufacturing: SOP for Environmental Monitoring in Gel Manufacturing Areas – V 2.0

Posted on By

Gel Manufacturing: SOP for Environmental Monitoring in Gel Manufacturing Areas – V 2.0

Standard Operating Procedure for Environmental Monitoring in Gel Manufacturing Areas


Department Gel Manufacturing
SOP No. SOP/GM/118/2025
Supersedes SOP/GM/118/2022
Page No. Page 1 of 14
Issue Date 09/06/2025
Effective Date 11/06/2025
Review Date 09/06/2027

1. Purpose

To define a procedure for routine environmental monitoring (EM) of classified areas within gel manufacturing facilities to ensure compliance with GMP and minimize risk of contamination to drug products.

2. Scope

This SOP applies to all cleanrooms and controlled areas where gel manufacturing, filling, packaging, or

ancillary operations are carried out.

3. Responsibilities

  • Microbiology Analyst: Conducts EM as per the defined schedule and documents results.
  • QA Executive: Reviews trends and investigates out-of-limit (OOL) conditions.
  • Maintenance Team: Ensures HVAC and HEPA systems are operating within specification.
  • Production Officer: Coordinates EM activity with batch production planning.

4. Accountability

Head – Quality Assurance

See also  Gel Manufacturing: SOP for Accelerated Stability Studies for Prototype Gels - V 2.0

5. Procedure

5.1 Types of Environmental Monitoring

  1. Viable Monitoring: Settle plates, contact plates, swabs, and air sampling.
  2. Non-Viable Monitoring: Particulate monitoring using laser particle counters.

5.2 Locations and Frequency

Identify monitoring locations as per the Environmental Monitoring Plan (EMP), covering:

  • Class A/B areas: During operations (e.g., filling, open product exposure).
  • Class C/D areas: Before and after cleaning, or during peak activity periods.

5.3 Methods and Equipment

  1. Settle Plates: Use sterile agar plates exposed for 4 hours at defined locations.
  2. Contact Plates: Press on surfaces like benches, gloves, and walls.
  3. Swabs: Collect from irregular surfaces using sterile swab sticks.
  4. Air Sampling: Use active air samplers (1 m³) near critical points.
  5. Particle Counters: Calibrated devices used for airborne non-viable particles.

5.4 Sample Handling

  1. Label all plates with location code, date, and analyst initials.
  2. Transport samples to microbiology lab in clean containers.
  3. Incubate viable samples at 30–35°C for 3 days and 20–25°C for 2 days.
See also  Gel Manufacturing: SOP for Cleaning Logs Documentation for Mixing Vessels - V 2.0

5.5 Limits and Alert Levels

Follow regulatory specifications (EU GMP, WHO TRS 961) for microbial and particulate counts:

  • Grade A: <1 CFU / <3520 particles ≥0.5 µm
  • Grade B, C, D: Defined as per facility-specific limits in EMP.

5.6 Deviation and OOL Handling

  1. Initiate deviation form for OOL events or any EM anomalies.
  2. Investigate source (e.g., HVAC failure, gowning breach).
  3. Implement CAPA and record all actions taken.

5.7 Trend Analysis

  1. Compile monthly trend charts for each monitored location.
  2. Use trend data to identify recurrent contamination risks or areas for improvement.

5.8 Record Keeping

  1. Maintain all raw data, EM forms, and summary reports.
  2. Retain records for a minimum of 5 years or as per regulatory requirement.

6. Abbreviations

  • EM: Environmental Monitoring
  • OOL: Out of Limit
  • HVAC: Heating, Ventilation, and Air Conditioning
  • CFU: Colony Forming Units

7. Documents

  1. Environmental Monitoring Plan – Annexure-1
  2. EM Sampling Log – Annexure-2
  3. EM Trend Report Template – Annexure-3
See also  Gel Manufacturing: SOP for Troubleshooting Gel Filling Machines - V 2.0

8. References

  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
  • WHO TRS 961 Annex 6 – GMP for HVAC Systems
  • ISO 14644: Cleanroom Classification

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Jr. Production Chemist QA Executive Head – Manufacturing
Department Gel Manufacturing Quality Assurance Manufacturing

11. Annexures

Annexure-1: Environmental Monitoring Plan

Location Class Method Frequency
Filling Room A/B Settle Plates, Air Sampling Daily
Compounding Room C Swab, Contact Plates Weekly
Corridor D Settle Plates Monthly

Annexure-2: EM Sampling Log

Date Location Code Method Result Analyst Initials Comments

Annexure-3: EM Trend Report

Month Location CFU Range Alert Level Action Taken

Revision History

Revision Date Revision No. Change Description Reason Approved By
20/05/2022 1.0 Initial version New SOP QA Head
09/06/2025 2.0 Updated to include particle monitoring and revised annexures Periodic review QA Head
Gels V 2.0 Tags:gel excipients SOP, gel extrudability SOP, gel formulation process guidelines, gel formulation safety SOP, gel formulation SOP template, gel homogenization SOP, gel ingredient weighing SOP, gel labeling and documentation SOP, gel microbial contamination SOP, gel packaging SOP, gel viscosity measurement SOP, gel viscosity testing SOP, pharmaceutical gel SOP, quality control SOP gel formulations, SOP for carbopol gel formulation, SOP for gel pH adjustment, SOP for gel spreadability test, stability testing SOP gel, standard operating procedure gel preparation, topical gel manufacturing SOP

Post navigation

Previous Post: Elixir Department: SOP for Using Pressure Gauges During Filtration – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Environmental Monitoring in Dispensing Rooms – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version